Altered intragraft immune responses and imroved renal function in MHC class II-deficient mouse kidney allografts

Transplantation

Volumn 69, Issue 10, 2000, Pages 2137-2143

  Mannon, Roslyn B ^a   Doyle, Carolyn ^b   Griffiths, Robert ^a   Bustos, Matilde ^c   Platt, Jeffrey L ^d   Coffman, Thomas M ^a  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NAVARRA   (Spain)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOPATHOLOGY; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0034720615     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200005270-00031     Document Type: Article

References (38)

1. Gould DS, Auchincloss H Jr. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 1999; 20: 77.
2. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ. The detailed distribution of MHC class II antigens in normal human organs. Transplantation 1984; 38: 293.
3. Benson EM, Colvin RB, Russell PS. Induction of IA antigens in murine renal transplants. J Immunol 1985; 7.
4. Halloran PF, Wadgymar A, Autenried P. The regulation of expression of major histocompatibility complex products. Transplantation 1986; 41: 413.
5. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997; 100: 1199.
6. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990; 49: 201.
7. Krieger NR, Fathman CG. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection. J Heart Lung Transplant 1997; 16: 263.
8. Cobbold SP, Jayasuriya A, Nash A, Pospero TD, Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984; 312: 548.
9. Herbert J, Roser B. Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants. Transplantation 1988; 46: 128S.
10. Cobbold SP, Martin G, Qin S, Waldmann H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986; 323: 164.
11. Pearson TC, Darby CR, Bushell AR, West LJ, Morris PJ, Wood KJ. The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model. Transplantation 1993; 55: 361.
12. + cells are essential for allorejection. J Exp Med 1996; 184: 2013.
13. -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J Immunol 1996; 156: 4114.
14. intermediate expression in CD8-deficient mice. Eur J Immunol 1996; 26: 213.
15. Campos L, Naji A, Deli BC, et al. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation 1995; 59: 187.
16. Dierich A, Chan SH, Benoist C, Mathis D. Graft rejection by T cells not restricted by conventional major histocompatibility complex molecules. Eur J Immunol 1993; 23: 2725.
17. Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA1993; 90: 3373.
18. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H Jr. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med 1994; 179: 865.
19. + T cells in major histocompatibility complex class II-deficient mice. Science 1991; 253: 1417.
20. Mannon RB, Nataraj C, Kotzin BL, et al. Rejection of kidney allografts by MHC class I deficient mice. Transplantation 1995; 59: 746.
21. Mannon RB, Kopp JB, Ruiz P, et al. Chronic rejection of mouse kidney allografts. Kidney Int 1999; 55: 1935.
22. Gomez-Morales M, Bustos M, Montes A, et al. Influence of intrarenal deposits of ciclosporin A on acute renal transplant rejection. Nephron 1995; 70: 402.
23. Sambrook J, Fritsch E, Maniatis T. Molecular cloning: a laboratory manual. 2nd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989.
24. + T cells from young and old mice. J Immunol 1993; 150: 3602.
25. Coffman T, Geier S, Ibrahim S, et al. Improved renal function in mouse kidney allografts lacking MHC class I antigens. J Immunol 1993; 151: 425.
26. Nesbitt T, Coffman TM, Griffiths R, Drezner MK. Cross-transplantation of kidneys in normal and hyp-mice: evidence that the hyp-mouse phenotype is unrelated to an intrinsic renal defect. J Clin Invest 1992; 89: 1453.
27. + T cell response in renal allograft rejection in the mouse. Transplantation 1996; 62: 96.
28. Nickerson P, Steiger J, Zheng XX, et al. Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? Transplantation 1997; 63: 489.
29. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Cytokines and the TH1/TH2 paradigm in transplantation. Curr Opinion Immunol 1994; 6: 757.
30. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
31. Russell ME, Hancock WW, Akalin E, et al. Chronic rejection in the LEW to F344 rat model: blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest 1996; 97: 833.
32. + T cells results in Th2 cytokine production and alternative mechanisms of allograft rejection. Transplantation 1995; 59: 1155.
33. Lakkis FG, Konieczny BT, Saleem S, et al. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J Immunol 1997; 158: 2443.
34. Nickerson P, Zheng XX, Steiger J, et al. Prolonged islet allograft acceptance in the absence of interleukin 4 expression. Transplant Immunol 1996; 4: 81.
35. Kim JJ, Nottingham LK, Sin JI, et al. CD8 positive T cells influence antigen-specific immune response through the expression of chemokines. J Clin Invest 1998; 102: 1112.
36. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993; 75: 135.
37. Ivashkiv LB, Ayres A, Glimcher LH. Inhibition of IFN-γ induction of class II MHC genes by cAMP and prostaglandins. Immunopharm 1994; 27: 67.
38. Platt JL. New directions for organ transplantation. Nature 1998; 392 supp: 11.